ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Innovent Biologics, Inc. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 24.45% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -14.98
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 43.91%, its profits have risen by 175.3% ; the PEG ratio of the company is 0.8
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Innovent Biologics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Innovent Biologics, Inc.
43.91%
46.32
52.28%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
45.86%
EBIT Growth (5y)
24.45%
EBIT to Interest (avg)
-14.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.44
Tax Ratio
43.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.37%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
136
Industry P/E
Price to Book Value
9.26
EV to EBIT
73.49
EV to EBITDA
57.56
EV to Capital Employed
15.38
EV to Sales
11.32
PEG Ratio
0.78
Dividend Yield
NA
ROCE (Latest)
20.92%
ROE (Latest)
6.82%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 13,169.33 MM
NET SALES(Q)
Highest at HKD 7,760.15 MM
RAW MATERIAL COST(Y)
Fallen by -6.17% (YoY
CASH AND EQV(HY)
Highest at HKD 20,306.44 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -79.64 %
DEBTORS TURNOVER RATIO(HY)
Highest at 8.93 times
-4What is not working for the Company
PRE-TAX PROFIT(Q)
Fallen at -79.19%
NET PROFIT(Q)
Fallen at -91.6%
Here's what is working for Innovent Biologics, Inc.
Operating Cash Flow
Highest at HKD 13,169.33 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
Highest at HKD 7,760.15 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Net Sales
At HKD 7,760.15 MM has Grown at 30.79%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Cash and Eqv
Highest at HKD 20,306.44 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -79.64 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 8.93 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -6.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 367.1 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 367.1 MM has Grown at 28.49%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Innovent Biologics, Inc.
Pre-Tax Profit
Fallen at -79.19%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Net Profit
Fallen at -91.6%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
